STAT+: Early findings in gene therapy death suggest CRISPR was not the cause
In February, four months after the first patient in a designer CRISPR therapy suddenly died,…
Category: Exclusive
The Biden administration will hang on to some Covid pandemic emergency powers
WASHINGTON — Even though the Biden administration is ending its highest-profile Covid-19 emergency declaration next…
STAT+: Google will let health care customers test its generative AI model, ramping up rivalry with GPT-4
Accelerating medicine’s AI race, Google is releasing a version of its generative language model to…
STAT+: FDA staff leaned toward rejecting Sarepta gene therapy before top official intervened
Reviewers at the Food and Drug Administration were leaning toward rejecting a closely watched gene…
STAT+: Senate hashing out policy details on generics, PBMs, insulin
WASHINGTON — Senators are slightly delaying their latest legislative push on health care, but as they…
STAT+: Sanders plans to haul insulin executives to testify in Senate
WASHINGTON — Sen. Bernie Sanders plans to call the chief executives of the country’s largest…
STAT+: FDA report details problems at Global Pharma plant involved in eye drop recall
Global Pharma Healthcare, whose eye drops have been linked to dozens of serious reactions, failed…
.jpg)
STAT+: Biogen’s Samantha Budd Haeberlein, an architect of Aduhelm, leaves company
Samantha Budd Haeberlein, the Biogen senior executive who supervised the development and controversial approval of…
HHS’ Becerra on enrolling in Medicare, annual Covid vaccines, and seniors’ mental health
WASHINGTON — The hottest birthday spot in town: A Hispanic senior center in northwest D.C….
.jpg)
STAT+: Calico looking for new chief scientist after celebrated biologist David Botstein quietly retires
Are you a promising middle or late-career scientist with a desire to extend human lifespan,…
STAT+: Verily leans into Onduo as it looks to enter the lucrative world of running medical research
The new, streamlined Verily will have one very recognizable component: its virtual care company Onduo,…
STAT+: Day One says drug shrinks tumors in common pediatric brain cancer, setting up potential approval
Day One Biopharmaceuticals said Sunday that a targeted therapy shrank tumors by at least 50%…
STAT+: Eric Lander’s next act: leading a nonprofit set on solving thorny scientific challenges
In January 2021, when President Biden tapped Eric Lander to serve as the White House…
STAT+: Backed by a longtime mental health leader, a new startup aims to build support for serious mental illness
The number of startups focused on mental health has surged in the wake of the…
STAT+: Thirty Madison, looking to stand out in a crowded telehealth market, quietly plans expansion into sleep care
In the fight to command the growing market for telehealth, Thirty Madison is staking out…
STAT+: Biogen’s new CEO, clear-eyed about company’s challenges, prepares to take the reins
Christopher Viehbacher, who will start as Biogen’s CEO on Monday, knows that running Biogen may…
STAT+: Death of patient in closely watched Alzheimer’s trial raises concern about risk for some groups
The experimental Alzheimer’s drug lecanemab, hailed after it slowed patients’ cognitive decline in a clinical…
STAT+: Inside Michelle McMurry-Heath’s departure from BIO: Firings, internal clashes, and a pivotal job review
WASHINGTON — Only two years ago, Michelle McMurry-Heath was named chief executive of BIO, the…
STAT+: Large insurer’s decision to cover some prescription digital therapies may be a milestone for app makers
A large commercial insurer’s decision to cover a controversial class of software-based treatments for psychiatric…
Biden officials scramble for a backup as Covid variants threaten a key therapy for immunocompromised people
WASHINGTON — Biden health officials are bracing for the prospect that the country’s sole preventive…
STAT+: Biogen CEO search focuses on scientists, with former J&J exec as a leading candidate
A senior researcher who was most recently at Johnson & Johnson has emerged as a…
STAT+: Medicare tasks a senior adviser with staffing its new drug pricing division
WASHINGTON — Medicare has tasked a senior adviser at the agency with assembling a small…
STAT+: Alzheimer’s clinical trials have a recruitment problem. Telehealth platform Ro thinks it can help
Telehealth company Ro has reached an agreement with the National Institute on Aging to create…
STAT+: Epic overhauls popular sepsis algorithm criticized for faulty alarms
Epic Systems has revamped its widely criticized sepsis prediction model in a bid to improve…
STAT+: Medicare lays out the bureaucracy it will need to negotiate drug prices
WASHINGTON — New documents obtained by STAT outline how Medicare is planning to build out…
STAT+: Democrats concede to clean user fee agreement to fund FDA
WASHINGTON — Democrats have conceded to Republican demands and agreed to fund the Food and…
STAT+: White House pitches drug pricing reforms as a way to extend cancer patients’ lives
WASHINGTON — The White House is pitching an added benefit to Democrats’ recent drug pricing…
Shakeup with Optum’s health data licensing sparks an outcry among scientists
A move by Optum to change longstanding practices for licensing data to academic institutions has…
STAT+: Lawmaker requests investigation into HCA over billing practices
WASHINGTON — A Democratic House lawmaker with oversight authority is calling for an investigation into the…
STAT+: FDA funding negotiations heat up ahead of September deadline
WASHINGTON — Negotiations are intensifying over massive, multibillion-dollar legislation to fund the Food and Drug…
STAT+: Calm’s head of science departs amid a shakeup at meditation app maker
In 2021, Jennifer Huberty left her post in academia to become the first full-time head…
STAT+: Ex-Google CEO’s VC firm brings in hype-busting researcher to expand its biotech investments
Innovation Endeavors, the venture capital firm co-founded by former Google chairman and CEO Eric Schmidt,…
STAT+: Novartis reports two children died from acute liver failure after treatment with Zolgensma gene therapy
Two children have died from acute liver failure after being administered Zolgensma, a pricey gene…
Researchers revive abandoned technique in effort to make artificial human eggs in a test tube
In a little-noticed study published earlier this year, scientists from Oregon Health & Science University…
White House to launch effort to develop next generation of Covid vaccines
The Biden administration is preparing a sweeping initiative to develop a next generation of Covid-19…
Biden picks renowned cancer surgeon Monica Bertagnolli as NCI chief
WASHINGTON — The Biden administration has selected Monica Bertagnolli, a renowned surgical oncologist, as the…
STAT+: In the search for an ARPA-H director, the White House is zeroing in on DARPA veterans
WASHINGTON — The White House is zeroing in on former DARPA officials as candidates to…
STAT+: Klobuchar, Porter call for FTC to investigate price hikes by Janssen, Bristol Myers Squibb
WASHINGTON — Two prominent Democratic lawmakers are requesting that the Federal Trade Commission investigate whether…
Genetic data indicate at least two separate monkeypox outbreaks underway, suggesting wider spread
The Centers for Disease Control and Prevention said Friday that new genetic sequencing data indicate…
STAT+: Senate FDA legislation will include dietary supplement, cosmetic reforms
WASHINGTON – Senate lawmakers are set to unveil draft legislation as soon as Monday that…
White House documents detail a looming squeeze on Covid-19 boosters
WASHINGTON — The White House could run out of Covid-19 vaccines if it moves forward…
Prisons didn’t prescribe much Paxlovid or other Covid-19 treatments, even when they got the drugs
Federal prisons utilized just a fraction of the antiviral drugs they were allocated to keep…
STAT+: Gates Foundation CEO has ‘zero expectation’ that Melinda French Gates will step down as co-chair after divorce
LOS ANGELES — In the most extensive public comments about the stewardship of the Bill…
White House’s Jen Psaki offered a binder full of Covid spending details. Taking a peek was a process
WASHINGTON — It was a striking visual for the television cameras. White House Press Secretary…
STAT+: Justice Department probes Bausch Health over marketing for dermatology drugs
Bausch Health is being investigated by U.S. authorities in connection with marketing of four medicines…
STAT+: Warren, Grassley threaten to slap FDA with a 30-day deadline for OTC hearing aid rules
WASHINGTON – A bipartisan duo of senators is done waiting for the Food and Drug…
STAT+: Douglas Melton, noted stem cell researcher, leaves Harvard for Vertex to create diabetes treatments
Douglas Melton, one of the leading stem cell researchers in the world, is leaving Harvard…
NIH’s cancer chief, Ned Sharpless, to step down
Ned Sharpless, the director of the National Cancer Institute, is stepping down at the end…
STAT+: Biden’s high-stakes biomedical science agency ARPA-H will be part of the NIH — but there’s a twist
WASHINGTON — President Biden’s “moonshot” biomedical research agency will be housed within the National Institutes…
STAT+: Lawmakers and a Pelosi aide turn lobbyist to push for new health agency’s independence
WASHINGTON — Health secretary Xavier Becerra is suddenly the target of a frenzied lobbying campaign…